Etodolac Prolonged Release Tablets IP 600 Mg - TODAC 600 ER Tablets

TODAC 600 ER Tablets
Composition:- Etodolac 600 mg Extended Release

TODAC 600 ER Tablets – Etodolac Prolonged Release Tablets IP 600 Mg is a nonsteroidal anti-inflammatory drug (NSAID) that works by selectively inhibiting cyclooxygenase-2 (COX-2), reducing the production of prostaglandins responsible for pain and inflammation. The extended-release formulation provides long-lasting therapeutic effects, making it ideal for conditions requiring consistent pain management. Its balanced COX-1 sparing action minimizes the risk of gastrointestinal irritation commonly associated with NSAIDs.

Key Points of Etodolac Prolonged Release Tablets IP 600 Mg – TODAC 600 ER Tablets
✅ Reduced Dose frequency with prolonged relief: Extended-release formulation ensures sustained pain and inflammation control throughout the day, reducing the need for frequent dosing.
✅ Selective COX-2 Inhibition: Provides effective anti-inflammatory and analgesic effects with a reduced risk of gastrointestinal side effects compared to traditional NSAIDs.
✅ Versatile symptom management: Effectively manages acute and chronic pain, including osteoarthritis, rheumatoid arthritis, and post-surgical inflammation.

Can be Prescribed by:
👨‍⚕️ Orthopedicians 
👨‍⚕️ Rheumatologists 
👨‍⚕️ General Physicians
👨‍⚕️ Healthcare practitioner

📢 Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.